Champions Oncology (CSBR) EBT Margin (2010 - 2026)
Champions Oncology (CSBR) posted quarterly EBT Margin of 3.58% for Q2 2026, up 1232.0% year-over-year from 0.27% in Q2 2025, and down 149.98% quarter-over-quarter from 1.43% in Q1 2026.
Champions Oncology (CSBR) EBT Margin (2010 - 2026) Analysis & Trends
Champions Oncology's EBT Margin history runs 17 years deep, the most recent figure standing at 3.58% for Q2 2026.
- In Q2 2026, EBT Margin rose 1232.0% year-over-year to 3.58%; the TTM figure through Apr 2026 stood at 1.56% (down 969.0% YoY), while the FY2026 annual figure was 1.56%, down 969.0% from the prior year.
- EBT Margin for Q2 2026 stood at 3.58%, down from 1.43% in the prior quarter.
- The five-year high for EBT Margin was 26.52% in Q1 2025, with the low at 20.96% in Q1 2024.
- The 5-year median for EBT Margin is 2.44% (2022), against an average of 4.36%.
- The sharpest annual moves came in 2025 and 2026: EBT Margin soared 4747 bps in 2025, then tumbled 2795 bps in 2026.
- Champions Oncology's EBT Margin stood at 0.01% in 2022, then sank by 127001 bps to 17.8% in 2023, then jumped by 131 bps to 5.48% in 2024, then slumped by 69 bps to 1.7% in 2025, then sank by 311 bps to 3.58% in 2026.
- Business Quant data shows CSBR's EBT Margin at 3.58% in Q2 2026, 1.43% in Q1 2026, and 1.7% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 35.71% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -528.97% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 18.33% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 13.77% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -2.67% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 12.09% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -25.06% |
| 10 | Champions Oncology | 71.17 Mn | 71.17 Mn | 7.03 Mn | -3.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -3.58% |
| Jan 31, 2026 | -1.43% |
| Oct 31, 2025 | 1.70% |
| Jul 31, 2025 | -3.23% |
| Apr 30, 2025 | -15.90% |
| Jan 31, 2025 | 26.52% |
| Oct 31, 2024 | 5.48% |
| Jul 31, 2024 | 9.49% |
| Apr 30, 2024 | -1.36% |
| Jan 31, 2024 | -20.96% |
| Oct 31, 2023 | -17.80% |
| Jul 31, 2023 | -20.21% |
| Apr 30, 2023 | -19.44% |
| Jan 31, 2023 | -18.96% |
| Oct 31, 2022 | -0.01% |
| Jul 31, 2022 | -2.20% |
| Apr 30, 2022 | -2.69% |
| Jan 31, 2022 | 6.05% |
| Oct 31, 2021 | 2.45% |
| Jul 31, 2021 | -1.40% |